Polyplus Raises $3.3M in Private Financing | GenomeWeb

Polyplus Transfection said this week that it has raised €2.5 million ($3.3 million) through a round of private financing.

The round brings in new investors Alsace Inter Regio Fonds d’Investissement and Sudinnova, while existing investors CIC Vizille Capital Innovation and CIC Finance also participated.

The company said it will use the funds to advance new siRNA delivery compounds and add 10 new researchers and lab technicians, which would bring its total headcount to 40.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.